Jean-Pierre Lehner
Chairman at YSOPIA Biosciences SA
Profile
Jean-Pierre Lehner is currently the Chairman at YSOPIA Biosciences SA. He also holds director positions at AptamiR Therapeutics, Inc., Eligo Bioscience SA, and Curio Digital Therapeutics, Inc. Previously, he served as the Chief Medical Officer & Senior Vice President at Sanofi from 2009 to 2013.
He also held the same position at Sanofi-Aventis U.S.
LLC.
Lehner earned a doctorate degree from Université Paris 1 Panthéon-Sorbonne.
Jean-Pierre Lehner active positions
Companies | Position | Start |
---|---|---|
Eligo Bioscience SA
Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Director/Board Member | - |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Chairman | 07/04/2022 |
AptamiR Therapeutics, Inc.
AptamiR Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services AptamiR Therapeutics, Inc. develops a revolutionary treatment for human obesity. The private company is based in Naples, FL. The company was founded by Marc Thibonnier. | Director/Board Member | - |
Curio Digital Therapeutics
Curio Digital Therapeutics Packaged SoftwareTechnology Services Curio Digital Therapeutics is a digital therapeutics company that focuses on supporting women's mental and behavioral health across all ages and physiological conditions. The company is based in Princeton, NJ. The company designs customized interventions that are backed by years of research and successful clinical trials. Curio's solutions are digitally accessible to women anytime, anywhere, through self-guided programs, health coaches, connectivity with providers, and timely behavioral health support. The company was founded by Shailja Dixit, who has been the CEO since incorporation. | Director/Board Member | - |
Former positions of Jean-Pierre Lehner
Companies | Position | End |
---|---|---|
SANOFI | Chief Tech/Sci/R&D Officer | 31/12/2012 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 30/12/2012 |
Training of Jean-Pierre Lehner
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SANOFI | Health Technology |
Private companies | 5 |
---|---|
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
AptamiR Therapeutics, Inc.
AptamiR Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services AptamiR Therapeutics, Inc. develops a revolutionary treatment for human obesity. The private company is based in Naples, FL. The company was founded by Marc Thibonnier. | Commercial Services |
Eligo Bioscience SA
Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Health Services |
Curio Digital Therapeutics
Curio Digital Therapeutics Packaged SoftwareTechnology Services Curio Digital Therapeutics is a digital therapeutics company that focuses on supporting women's mental and behavioral health across all ages and physiological conditions. The company is based in Princeton, NJ. The company designs customized interventions that are backed by years of research and successful clinical trials. Curio's solutions are digitally accessible to women anytime, anywhere, through self-guided programs, health coaches, connectivity with providers, and timely behavioral health support. The company was founded by Shailja Dixit, who has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Jean-Pierre Lehner